Mechanisms of PD-1/PD-L1 expression and prognostic relevance in non-Hodgkin lymphoma: a summary of immunohistochemical studies

Immune checkpoint blockade therapeutics, notably antibodies targeting the programmed death 1 (PD-1) receptor and its PD-L1 and PD-L2 ligands, are currently revolutionizing the treatment of cancer. For a sizeable fraction of patients with melanoma, lung, kidney and several other solid cancers, monocl...

Descripción completa

Detalles Bibliográficos
Autores principales: Gravelle, Pauline, Burroni, Barbara, Péricart, Sarah, Rossi, Cédric, Bezombes, Christine, Tosolini, Marie, Damotte, Diane, Brousset, Pierre, Fournié, Jean-Jacques, Laurent, Camille
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546533/
https://www.ncbi.nlm.nih.gov/pubmed/28402953
http://dx.doi.org/10.18632/oncotarget.16680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546533/
https://www.ncbi.nlm.nih.gov/pubmed/28402953
http://dx.doi.org/10.18632/oncotarget.16680

Ejemplares similares